Clinical Trial Update: High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose intravenous thiamine to prevent delirium in patients undergoing allogeneic hematopoietic stem cell transplantation; study com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium
• Hematopoietic Stem Cell Transplantation
• Thiamine Deficiency

Drugs mentioned

• Thiamine (thiamine)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Hematopoietic Stem Cell Transplantation, Delirium | Phase 2 | Status: COMPLETED | Results posted: 2021-04-26